Are circulating tumor cells (CTCs) a feasible tool for predicting disease recurrence and survival in nonmetastatic (M0) colorectal cancer (CRC)? This is an ASCO Meeting Abstract from the 2015 ...
Results differed by caregiver group, but caregivers reporting greater average subjective burden typically also reported greater objective burden. A recent analysis of caregiver burden sheds light on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results